malaria

See the following -

By 2050, Superbugs Will Kill 10 Million People A Year

Gwynn Guilford | Quartz | December 23, 2014

A scourge is emerging across the rich and poor worlds alike, one that will claim 10 million lives a year by mid-century. Watch out for the “superbugs”—pathogens that even antibiotics can’t kill...

Read More »

Costa Ricans Design Mobile App to Report Dengue Breeding Sites

A free app that allows the public to report pools and other areas of water where dengue-carrying mosquitoes have laid their eggs could help control outbreaks of the disease in Costa Rica and beyond, say its developers and health officials. Costa Rican company GeoTecnologías joined forces with the country’s Ministry of Health to develop the Dengue Breeding Report application. The app allows the public to report mosquito ‘hatcheries’ to the ministry and will allow the ministry to map this data. Read More »

CSIR Pushes For TB, Malaria Drug Finds [India]

Himanshi Dhawan | The Times of India | September 18, 2013

NEW DELHI: Giving crowd sourcing a whole new meaning, scientists at the Council for Scientific and Industrial Research (CSIR) have initiated a country-wide venture to build a chemical library with diverse compounds that will successfully drive drug discovery programmes, particularly for neglected diseases like tuberculosis and malaria.

Read More »

CSIR, Royal Society Of Chemistry Team Up To Support OSDD Efforts: Minister

Staff Writer | Pharmabiz.com | August 9, 2013

Council of Scientific and Industrial Research (CSIR)  had signed a memorandum of understanding (MoU) with Royal Society of Chemistry of London to support  drug discovery efforts through the Open Source Drug Discovery (OSDD) , the Parliament has been told. Read More »

Drug Resistance Grows Menacingly

Nana Taona Kuo | Bangkok Post | December 21, 2015

Every five minutes a child in Southeast Asia dies from an infection caused by drug-resistant bacteria -- a situation that is likely to get worse. Anti-microbial resistance, which happens when micro-organisms become less susceptible to antibiotics, is making diseases more difficult to contain and harder to cure. Diseases we no longer fear, such as pneumonia and tuberculosis, are re-emerging as major killers, as the tools we use to fight them become less effective.

Read More »

EU In 'Denial' That Sick Economy Costs Lives, Health Experts Say

Staff Writer | CNBC | March 27, 2013

Europe's financial crisis is costing lives, with suicides and infectious diseases on the rise, yet politicians are not addressing the problem, health experts said on Wednesday. Read More »

Funding Crunch Hits Neglected Diseases Plan

Staff Writer | SciDev.Net | April 29, 2014

The Open Source Drug Discovery (OSDD) programme — a global collaborative initiative supported by the Indian government to find affordable treatment for neglected tropical diseases — has suffered a temporary setback due to a funds crunch caused by tardy submission of funding estimates. Read More »

Funds Crunch Hits India's Drug Development Project

Joe C. Mathew | Business World | April 5, 2014

Lack of funds is threatening the smooth progress of India’s unique Open Source Drug Discovery (OSDD) project, a first of its kind attempt to develop drugs for neglected diseases, when it is entering a crucial phase of research. Prime Minister Manmohan Singh had in February announced that OSDD, the pet project of the Council of Scientific and Industrial Research (CSIR), had identified a lead (potential drug candidate) for tuberculosis (TB).  

Read More »

Gates Foundation’s Strict Open Access Policy may have Domino Effect

The Bill & Melinda Gates Foundation, a major supporter of health and development research, is to introduce an open access policy next month for the studies it funds that goes further than most other research funders. The policy “will enable other researchers to access the latest evidence and draw on it to advance their own research” to help tackle malnutrition, infectious diseases, and child and maternal mortality, writes Trevor Mundel, the foundation’s president of global health, on the organization's website.

Read More »

Hesperian Health Guides Releases Open Copyright Apps

Hesperian Health Guides released the Android version of their Safe Pregnancy and Childbirth app Friday, completing the new suite of free digital tools Hesperian made available in late February. These new digital tools, which were developed by Hesperian in partnership with The UnaMesa Association, are designed to provide community health workers worldwide with quick medical references and source content for training. The new digital tools suite consists of the Pregnancy and Safe Childbirth Application, a searchable HealthWiki, and an online image library. Read More »

How IBM’s STEM Uses Big Data To Help Fight Infectious Diseases

Dean Takahashi | MedCity News | September 30, 2013

IBM has teamed up with university researchers to use big data and analytics to predict the outbreak of deadly diseases such as Dengue fever and Malaria. Read More »

How OpenMRS is Used to Fight Malaria in Endemic Areas

Children receiving care at a health clinic using OpenMRS in rural Uganda. Statistics from the Ministry of Health show that malaria is still the leading cause of death in Uganda, accounting for over 27% of deaths. OpenMRS is an electronic medical record platform designed to be used in low-resource environments where malaria and many other deadly diseases are endemic such as Uganda, where malaria is the primary cause of death in children. OpenMRS is currently used in over 1,800 medical clinics in 64 countries, providing the health information technology infrastructure that is foundational to over 6.3 million patients...

Read More »

India's Open Source Drug Discovery Program Faces Lack Of Funding

Marcus Johnson | Bioresearch Online | April 7, 2014

India's Open Source Drug Discovery Program, or OSDD, ran out of funding last week, as the ministry of science and technology did not clear the cabinet note to extend the project's funding on time. OSDD was created in 2008 in an effort to develop new drugs to treat neglected diseases, including Tuberculosis, Malaria, and Leishmaniasis.

Read More »

Japanese Drugmakers Open 'Libraries' In $100 Million Health Project

Ben Hirschler | Reuters | May 30, 2013

Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientists hunting new treatments for malaria, tuberculosis and other diseases affecting the world's poor. Read More »

Last Mile: A Matter of Life and Death

Press Release | University at Buffalo | June 16, 2017

Access to essential medicines is not only about the development and cost of pharmaceuticals but also supply chain logistics. The "last mile" plays a particularly important (and challenging) role in low- and middle-income countries, such as Uganda. Industrial and systems engineering research reveals major disparities in access to essential medicines. Although Malaria accounts for 50% of a country's morbidity and mortality, some districts only have 50% of public health facilities with regular supplies of therapies...